Abstract
Rezumat
Introducere. Ficatul gras nonalcoolic (NAFLD) este considerat expresia hepatică a sindromului metabolic, întrucât cele două afec iuni împart manifestări clinice similare. 
Scop. Scopul acestui studiu a fost de a eviden ia, în rândul popula iei diabetice, rela ia dintre gradul de încărcare grasă hepatică și prezen a criteriilor de sindrom metabolic.

Material și metodă. A fost realizat un studiu observa ional pe un număr de 92 subiec i cu diabet zaharat de tip 2. S-au urmărit indicii antropometrici, profilul lipidic, tensiunea arterială și încărcarea grasă hepatică, utilizând ultrasonografia abdominală.
Rezultate. Vârsta medie a lotului studiat a fost de 60,38 ± 10,37 ani, cu o reparti ie aproximativ egală în func ie de sex (48% bărba i și 52% femei
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INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic affection and it is strongly associated with cardiovascular disease. NAFLD is considered the hepatic expression of the metabolic syndrome (MS), sharing similar clinical manifestations . The (1) prevalence of this hepatic pathology is higher in subjects with type 2 diabetes mellitus (DM2). (2) DM2, even in subjects with a normal body mass index (BMI) . (3) The first diagnostic criteria were described in 1999 , when NAFLD was divided into four (4) subtypes: type 1 -only fatty liver loading, ( 5 ) triglycerides content in human liver tissue is 5,5% of its weight . Histologically, liver (6, 7) steatosis is considered when > 5% of the hepatocytes present macrovesicular fatty degeneration . (8, 9, 10) The relationship between obesity and hepatic steatosis is wellknown. The global burden of obesity is associated with a high prevalence of metabolic syndrome and NAFLD. NHANES survey results showed that both obesity and NAFLD are incresing . (11) The strong link between metabolic syndrome NAFLD is associated with insulinresistance and hepatic insulin inability in stopping hepatic glucose production . This leads to (12) mild hyperglycemia and stimulation of i n s u l i n s e c r e t i o n , r e s u l t i n g i n hyperinsulinemia. Normally insulin inhibits the hepatic production of very low density lipoprotein cholesterol (VLDLc). The overproduction of VLDLc and the inability of insulin to inhibit this process is correlated with the hepatic fatty loading . (13) Liver fat content is associated with the components of the metabolic syndrome, independent of the BMI. Furthermore, hepatic steatosis is reported to be four times more frequent among pacients with metabolic syndrome compared to control subjects . Thus, metabolic syndrome is (14) universally recognised as the main risk factor for NAFLD and it is suggested that fatty liver might be included as a criteria for metabolic syndrome .
(15)
AIMS AND OBJECTIVES
The aim of the study was to determine the prevalence of NAFLD among DM2 subjects and to evaluate the link between the severity of hepatic steatosis and the presence of metabolic syndrome criteria.
MATERIALS AND METHODS
An observational study was conducted on 92 DM2 subjects. They were evaluated regarding fatty liver loading using abdominal ultrasonography, anthropometric indices, lipid profile and blood pressure measurment.
The inclusion criteria for the study were DM2 treated with oral drugs and/or diet and the exclusion criteria were represented by insulin therapy, viral hepatic infection (B,C),
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Internal
The level of hepatic steatosis was assessed using a portable ultrasound Carewell 12 with convex probe of 3,5 MHz. All the subjects were evaluated by the same investigator.
The abdominal ultrasonographies were taken after fasting for at least 8 hours, in order to avoid abdominal bloating.
The patients were evaluated regarding the components of the metabolic syndrome, using IDF criteria : l Hypertriglyceridemia (>150 mg/dl).
l Low values for high density lipoprotein cholesterol (HDLc) (< 40 mg/dl in men, <50 mg/dl in women).
l Hyperglycemia or DM2 (this criteria was met for all the included subjects)
The criteria for metabolic syndrome were met in the presence of three of the five conditions (abdominal obesity -mandatory) (16).
The database was created in Microsoft Excel, without including ID data of the subjects. The statistical analysis was made in Statistica, version 7.0. We considered p < 0.05 as statistically significant.
RESULTS
The group of 92 subjects was represented by 44 men (47.83%) and 48 women (52.17%).
According to the provenance environment, 
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The frequency of severe steatosis cases was significantly higher in subjects with metabolic syndrome (32,43% compared to 5,88%, p=0,01) and the normal liver cases were associated with subjects without metabolic syndrome (23,53% to 6,76%, p=0,02).
In addition to these findings, there was a statistically significant relationship between fatty liver loading and the number of metabolic syndrome criteria (Figure 2 ).
DISCUSSION AND CONCLUSION
The prevalence of hepatic steatosis in the studied group was more than 90%, data which is also shown in other studies, where the prevalence of this hepatic condition is mentioned between 70 and 90% among patients with DM2 . The prevalence is (17, 18) even higher in obese subjects . The high (19) prevalence of steatosis obtained in our research might be explained by the particular eating habits in our country (high saturated fats diet) combined with a sedentary lifestyle. As regards the studied group, we noticed no statistically significant correlations according to sex regarding the incidence of normal liver and hepatic steatosis cases, although other researchers claim that males present a higher risk for hepatic steatosis . (20) Visceral fat seems to be closely correlated with liver fatty load (14) . This explains to some extent the association between metabolic syndrome and NAFLD. In addition to this, the independent relationship between central obesity and increased morbidity and m o r t a l i t y i s w e l l e s t a b l i s h e d .
( 2 1 ) H y p e r l i p i d e m i a , e s p e c i a l l y d u e t o hypertriglyceridemia is a primary risk factor for NAFLD and it even represents a consequence of NAFLD . In our study, (22) serum triglyceride level was significantly correlated with the degree of hepatic steatosis.
DM2 is a major health problem, affecting nearly 350 million people. Diabetes and NAFLD are particularly closely related . (23, 24) Prevalence of NAFLD was proved to be higher in patients with DM2 and these subjects have a high risk of developing nonalcoholic steatohepatitis (NASH) . The (25) 
National
Health and Nutrition Examination Survey
( N H A N E S ) s h o w e d t h a t D M 2 i s a n independent predictor for NAFLD (26) . There is evidence that the reverse relationship is also true: in subjects without DM2, NAFLD might be a predictor for the incidence of diabetes . (27) A japanese study showed that subjects with metabolic syndrome are prone to develop NAFLD . The association between NAFLD (28) and metabolic syndrome might be the consequence of insulinresistance. Our study
shows that the frequency of severe steatosis General Reviews 57 cases were significantly higher in subjects with metabolic syndrome. Abdominal obesity and metabolic syndrome lead to hepatic steatosis, both by improving the transport of fatty acids by the liver and by increasing hepatic lipogenesis which is associated with hyperinsulinemia . At the same time, the (29) associated insulinresistence may also worsen metabolic syndrome.
The close link between fatty liver, obesity and cardiometabolic risk factors lead to the idea that hepatic steatosis may be a new component of the metabolic syndrome . We (30) conclude that NAFLD is a risk factor regarding cardiovascular disease and it can be seen as the hepatic manifestation of the metabolic syndrome.
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